BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Modak AS. Single time point diagnostic breath tests: a review. J Breath Res 2010;4:017002. [DOI: 10.1088/1752-7155/4/1/017002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Agapiou A, Mochalski P, Schmid A, Amann A. Potential Applications of Volatile Organic Compounds in Safety and Security. Volatile Biomarkers. Elsevier; 2013. pp. 514-58. [DOI: 10.1016/b978-0-44-462613-4.00024-6] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
2 Modak AS. Barriers to overcome for transition of breath tests from research to routine clinical practice. J Breath Res 2011;5:030202. [DOI: 10.1088/1752-7155/5/3/030202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
3 Luque de Castro M, Fernández-peralbo M. Analytical methods based on exhaled breath for early detection of lung cancer. TrAC Trends in Analytical Chemistry 2012;38:13-20. [DOI: 10.1016/j.trac.2012.03.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
4 Amann A, Corradi M, Mazzone P, Mutti A. Lung cancer biomarkers in exhaled breath. Expert Review of Molecular Diagnostics 2014;11:207-17. [DOI: 10.1586/erm.10.112] [Cited by in Crossref: 114] [Cited by in F6Publishing: 103] [Article Influence: 14.3] [Reference Citation Analysis]
5 Opdam FL, Dezentje VO, den Hartigh J, Modak AS, Vree R, Batman E, Smorenburg CH, Nortier JW, Gelderblom H, Guchelaar HJ. The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels. Cancer Chemother Pharmacol 2013;71:593-601. [PMID: 23228987 DOI: 10.1007/s00280-012-2034-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
6 Beauchamp JD, Pleil JD. Breath: An Often Overlooked Medium in Biomarker Discovery. In: Seitz H, Schumacher S, editors. Biomarker Validation. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2015. pp. 75-93. [DOI: 10.1002/9783527680658.ch5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Amann A, Costello Bde L, Miekisch W, Schubert J, Buszewski B, Pleil J, Ratcliffe N, Risby T. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva. J Breath Res. 2014;8:034001. [PMID: 24946087 DOI: 10.1088/1752-7155/8/3/034001] [Cited by in Crossref: 284] [Cited by in F6Publishing: 237] [Article Influence: 35.5] [Reference Citation Analysis]
8 Costanzo MT, Boock JJ, Kemperman RHJ, Wei MS, Beekman CR, Yost RA. Portable FAIMS: Applications and Future Perspectives. Int J Mass Spectrom 2017;422:188-96. [PMID: 29335669 DOI: 10.1016/j.ijms.2016.12.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Amann A, Ligor M, Ligor T, Bajtarevic A, Ager C, Pienz M, Denz H, Fiegl M, Hilbe W, Weiss W, Lukas P, Jamnig H, Hackl M, Haidenberger A, Sponring A, Filipiak W, Miekisch W, Schubert J, Troppmair J, Buszewski B. Analysis of exhaled breath for screening of lung cancer patients. memo 2010;3:106-12. [DOI: 10.1007/s12254-010-0219-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
10 Pleil JD. Breath biomarkers in toxicology. Arch Toxicol 2016;90:2669-82. [DOI: 10.1007/s00204-016-1817-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
11 Amann A, Mochalski P, Ruzsanyi V, Broza YY, Haick H. Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties. J Breath Res 2014;8:016003. [PMID: 24566039 DOI: 10.1088/1752-7155/8/1/016003] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 7.6] [Reference Citation Analysis]
12 van den Anker J, Reed MD, Allegaert K, Kearns GL. Developmental Changes in Pharmacokinetics and Pharmacodynamics. The Journal of Clinical Pharmacology 2018;58:S10-25. [DOI: 10.1002/jcph.1284] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 16.0] [Reference Citation Analysis]
13 Modak AS. An Update on 13C-Breath Tests: The Transition to Acceptability into Clinical Practice. Volatile Biomarkers. Elsevier; 2013. pp. 244-62. [DOI: 10.1016/b978-0-44-462613-4.00014-3] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]
14 Mäkitie AA, Almangush A, Youssef O, Metsälä M, Silén S, Nixon IJ, Haigentz M Jr, Rodrigo JP, Saba NF, Vander Poorten V, Ferlito A. Exhaled breath analysis in the diagnosis of head and neck cancer. Head Neck 2020;42:787-93. [PMID: 31854494 DOI: 10.1002/hed.26043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Koc H, King J, Teschl G, Unterkofler K, Teschl S, Mochalski P, Hinterhuber H, Amann A. The role of mathematical modeling in VOC analysis using isoprene as a prototypic example. J Breath Res 2011;5:037102. [DOI: 10.1088/1752-7155/5/3/037102] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
16 Boujday S, de la Chapelle ML, Srajer J, Knoll W. Enhanced Vibrational Spectroscopies as Tools for Small Molecule Biosensing. Sensors (Basel) 2015;15:21239-64. [PMID: 26343666 DOI: 10.3390/s150921239] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]